Delivery Order SPE2DB20D2001-SPE2DB23FM53L
Award Date
5/15/23
Potential Completion Date
5/16/23
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,455.43 firm fixed-price delivery order is for ZORYVE 0.3% Cream, a pharmaceutical product, with a period of performance through January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for a Delivery Order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,712.54 Firm Fixed Price contract is for the delivery of ZORYVE 0.3% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,122.34 Firm Fixed Price Delivery Order contract is for the supply of ZORYVE 0.3% Cream 60GM, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2024 and was awarded on December 3, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,750.89 firm fixed-price delivery order is for the supply of ZORYVE 0.3% Cream, a topical medication, and has a completion date of June 14, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive...
This federal contract award, valued at $6,172.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ZORYVE 0.3% cream, a pharmaceutical product, with a period of performance through June 26, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,637.41, is for the delivery of ZORYVE 0.3% Cream 60GM, a pharmaceutical product. The contract has an ultimate completion date of October 24, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award, valued at $1,345.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product "ZORYVE 0.3% CREAM 60GM" with a performance period through December 5, 2024. The contract has a firm fixed-price pricing type and was not designated with any set-aside requirements, indicating open competition....
This federal contract award is a delivery order with a firm fixed price of $1,054.62 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% cream, a pharmaceutical product, with a final completion date of February 6, 2025. The contract is not designated as a set-aside and represents one of the many federal supply contracts that Amerisourcebergen holds...
This federal contract award, with the ID SPE2DX15D3020|SPE2DX25FPXTM, was granted to AmerisourceBergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,461.96 firm fixed-price delivery order is for the supply of the pharmaceutical product ZORYVE 0.3% Cream, 60GM. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the prescription drug ZORYVE 0.3% Cream 60GM. The contract has a firm fixed price of $2,423.28 and a completion date of November 6, 2024. This award is not associated with any set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...